Skip to main content
Clinical Trials/ISRCTN97241637
ISRCTN97241637
Completed
未知

An evaluation of the effectiveness of ibuprofen and morphine for acute pain in sickle cell disease: a double-blind, placebo-controlled randomised trial

orth West London Hospitals NHS Trust (UK)0 sites320 target enrollmentApril 8, 2009

Overview

Phase
未知
Intervention
Not specified
Conditions
Sickle cell disease
Sponsor
orth West London Hospitals NHS Trust (UK)
Enrollment
320
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 8, 2009
End Date
TBD
Last Updated
9 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
orth West London Hospitals NHS Trust (UK)

Eligibility Criteria

Inclusion Criteria

  • Adult patients with SCD of any phenotype and gender aged 16 years and over.

Exclusion Criteria

  • 1\. Patient has a history of allergic reaction to either morphine or ibuprofen
  • 2\. Patient has contraindications to morphine or ibuprofen, e.g. peptic ulcer disease, non\-steroidal anti\-inflammatory drug (NSAID)\-induced asthma
  • 3\. Patient in a drug dependency programme
  • 4\. Patient is on renal dialysis
  • 5\. Stroke within the last 6 weeks
  • 6\. Platelet count less than 50 x 10^9/l
  • 7\. Patient is pregnant or breastfeeding
  • 8\. Doctor unwilling to randomise the patient for other reasons
  • 9\. Previous participation in the trial

Outcomes

Primary Outcomes

Not specified

Similar Trials